Clinical Trial Update: Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating short-term intravenous fluids to prevent post-ERCP pancreatitis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Pancreatitis

Drugs mentioned

• Intravenous fluids (intravenous fluids)

Snippet

Sponsor: University of Calgary | Conditions: Post-ERCP Acute Pancreatitis | Phase 4 | Status: RECRUITING